IL206720A0 - Antigen-binding polypeptides against cartilage degeneration - Google Patents
Antigen-binding polypeptides against cartilage degenerationInfo
- Publication number
- IL206720A0 IL206720A0 IL206720A IL20672010A IL206720A0 IL 206720 A0 IL206720 A0 IL 206720A0 IL 206720 A IL206720 A IL 206720A IL 20672010 A IL20672010 A IL 20672010A IL 206720 A0 IL206720 A0 IL 206720A0
- Authority
- IL
- Israel
- Prior art keywords
- antigen
- binding polypeptides
- cartilage degeneration
- polypeptides against
- against cartilage
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 title 1
- 230000007850 degeneration Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2631708P | 2008-02-05 | 2008-02-05 | |
| US8887608P | 2008-08-14 | 2008-08-14 | |
| PCT/CH2009/000045 WO2009097704A1 (en) | 2008-02-05 | 2009-02-05 | Antigen-binding polypeptides against cartilage degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL206720A0 true IL206720A0 (en) | 2010-12-30 |
Family
ID=40568129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL206720A IL206720A0 (en) | 2008-02-05 | 2010-06-30 | Antigen-binding polypeptides against cartilage degeneration |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110002927A1 (enExample) |
| EP (1) | EP2240515A1 (enExample) |
| JP (1) | JP2011510667A (enExample) |
| CN (1) | CN101939335B (enExample) |
| AU (1) | AU2009212079B2 (enExample) |
| BR (1) | BRPI0907485A2 (enExample) |
| CA (1) | CA2712965A1 (enExample) |
| IL (1) | IL206720A0 (enExample) |
| RU (1) | RU2010136988A (enExample) |
| WO (1) | WO2009097704A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013540757A (ja) | 2010-09-24 | 2013-11-07 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル |
| CN104231086B (zh) * | 2013-08-27 | 2019-12-13 | 北京韩美药品有限公司 | 双功能融合蛋白及其制备方法和用途 |
| SG11201604227XA (en) * | 2013-12-13 | 2016-07-28 | Mercury Asset Man Co Ltd | Articular cartilage imaging composition |
| EP3978022A1 (en) * | 2016-05-06 | 2022-04-06 | The Brigham and Women's Hospital, Inc. | Binary self assembled gels for controlled delivery of encapsulated agents to cartilage |
| US11839605B2 (en) | 2018-10-11 | 2023-12-12 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| ES2424042T3 (es) * | 2005-06-07 | 2013-09-26 | Esbatech - A Novartis Company Llc | Anticuerpos estables y solubles que inhiben TNF± |
| EP3093026B1 (en) * | 2006-07-10 | 2020-07-01 | ESBATech, an Alcon Biomedical Research Unit LLC | Scfv antibodies which pass epithelial and/or endothelial layers |
-
2009
- 2009-02-05 CA CA2712965A patent/CA2712965A1/en not_active Abandoned
- 2009-02-05 WO PCT/CH2009/000045 patent/WO2009097704A1/en not_active Ceased
- 2009-02-05 RU RU2010136988/10A patent/RU2010136988A/ru unknown
- 2009-02-05 JP JP2010545343A patent/JP2011510667A/ja active Pending
- 2009-02-05 US US12/865,365 patent/US20110002927A1/en not_active Abandoned
- 2009-02-05 BR BRPI0907485-6A patent/BRPI0907485A2/pt not_active Application Discontinuation
- 2009-02-05 CN CN200980104195.1A patent/CN101939335B/zh not_active Expired - Fee Related
- 2009-02-05 EP EP09707332A patent/EP2240515A1/en not_active Withdrawn
- 2009-02-05 AU AU2009212079A patent/AU2009212079B2/en not_active Ceased
-
2010
- 2010-06-30 IL IL206720A patent/IL206720A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2712965A1 (en) | 2009-08-13 |
| JP2011510667A (ja) | 2011-04-07 |
| CN101939335B (zh) | 2015-02-11 |
| EP2240515A1 (en) | 2010-10-20 |
| WO2009097704A1 (en) | 2009-08-13 |
| BRPI0907485A2 (pt) | 2015-08-04 |
| AU2009212079B2 (en) | 2012-08-30 |
| RU2010136988A (ru) | 2012-03-20 |
| CN101939335A (zh) | 2011-01-05 |
| US20110002927A1 (en) | 2011-01-06 |
| AU2009212079A1 (en) | 2009-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2457110B (en) | Sifting containers | |
| EP2274687A4 (en) | ASSESSMENTS USING A MACHINE READABLE REPRESENTATION | |
| GB0804178D0 (en) | Moving mirror | |
| ZA201003850B (en) | Antigen-binding constructs | |
| EP2241578A4 (en) | ANTI-CLDN6 ANTIBODIES | |
| GB0821100D0 (en) | Antibodies | |
| ZA201006099B (en) | Anti-tyrp1 antibodies | |
| PL2254769T3 (pl) | Okucie | |
| AP00230S1 (en) | Container | |
| GB0902610D0 (en) | Materials | |
| GB0817677D0 (en) | construction materials | |
| GB2476226B (en) | Optimisation | |
| ZA201007976B (en) | Anti-pirb antibodies | |
| GB0816976D0 (en) | Protein | |
| IL206720A0 (en) | Antigen-binding polypeptides against cartilage degeneration | |
| PL2379978T3 (pl) | Dystrybutor płynów z symetrią obrotową | |
| GB0818356D0 (en) | Antibodies | |
| GB0809659D0 (en) | Polypeptides | |
| GB0911770D0 (en) | Antibody | |
| HK1149027A (en) | Antigen-binding polypeptides against cartilage degeneration | |
| GB0818627D0 (en) | Protein | |
| GB0812733D0 (en) | Self-coalescing materials | |
| GB0814373D0 (en) | Tissue-adhesive materials | |
| GB0817077D0 (en) | Proteins | |
| PL2149351T3 (pl) | Komponent endoprotezy |